Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02252380 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 1, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 2023 to Jun 2026 Completion date: Dec 2023 to Dec 2026v11 Show 1 more changeShow less
    • Completion date: Dec 2023 to Dec 2026
  2. Primary completion date: Dec 2021 to Jun 2023 Completion date: Dec 2021 to Dec 2023v10 Show 1 more changeShow less
    • Completion date: Dec 2021 to Dec 2023
  3. Re-verified, no change to tracked fieldsv9
  4. Primary completion date: Dec 2019 to Dec 2021 Trial status: Recruiting to Active, Not Recruiting · Completion date: Dec 2020 to Dec 2021 · Site details revised at 2 of 2 sitesv8 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Dec 2020 to Dec 2021
    • Site details revised at 2 of 2 sites
  5. Primary completion date: Dec 2018 to Dec 2019 Completion date: Dec 2018 to Dec 2020v7 Show 1 more changeShow less
    • Completion date: Dec 2018 to Dec 2020
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: Dec 2017 to Dec 2018v6
  2. Primary and study completion dates: Dec 2016 to Dec 2017v5
  3. Primary and study completion dates: May 2016 to Dec 2016v4
  4. Site contacts updated at 1 of 2 sitesv3
  5. Trial status: Not Yet Recruiting to Recruiting Start date: Nov 2014 to May 2015 · Study sites: 1 to 2v2 Show 2 more changesShow less
    • Start date: Nov 2014 to May 2015
    • Study sites: 1 to 2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The proposed study is to evaluate the effectiveness of ExAblate Transcranial MRgFUS as a tool for creating a unilateral lesion in the Vim thalamus or the globus pallidus (GPi) in patients with treatment-refractory symptoms of movement disorders.
Trial Details
NCT Number NCT02252380
Lead Sponsor InSightec
Conditions Movement Disorders, Essential Tremor, Holmes Tremor, Parkinson's Disease, Wilson's Disease, Huntington's Disease, Dystonia, Tardive Dyskinesia +1 more
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov